4,698 Shares in CVS Health Corporation $CVS Purchased by Calamos Wealth Management LLC

Key Points

• Calamos Wealth Management LLC has acquired 4,698 shares of CVS Health Corporation, valued at approximately $324,000, reflecting growing interest from institutional investors.
• CVS Health's stock recently received several positive analyst ratings upgrades, with price targets increased by firms such as Jefferies Financial Group and Leerink Partners.
• CVS Health announced a quarterly dividend of $0.665, which translates to an annual yield of 3.2%, highlighting its commitment to returning value to shareholders.

Calamos Wealth Management LLC bought a new position in shares of CVS Health Corporation (NYSE:CVS - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 4,698 shares of the pharmacy operator's stock, valued at approximately $324,000.

A number of other institutional investors have also added to or reduced their stakes in CVS. GAMMA Investing LLC boosted its holdings in CVS Health by 198.5% during the first quarter. GAMMA Investing LLC now owns 18,669 shares of the pharmacy operator's stock valued at $1,265,000 after purchasing an additional 12,415 shares in the last quarter. CWA Asset Management Group LLC acquired a new stake in CVS Health during the first quarter valued at approximately $366,000. Stonegate Investment Group LLC boosted its holdings in CVS Health by 103.3% during the first quarter. Stonegate Investment Group LLC now owns 18,495 shares of the pharmacy operator's stock valued at $1,253,000 after purchasing an additional 9,399 shares in the last quarter. Cullinan Associates Inc. boosted its holdings in CVS Health by 12.2% during the first quarter. Cullinan Associates Inc. now owns 44,459 shares of the pharmacy operator's stock valued at $3,012,000 after purchasing an additional 4,841 shares in the last quarter. Finally, Childress Capital Advisors LLC acquired a new stake in CVS Health during the first quarter valued at approximately $456,000. 80.66% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. Jefferies Financial Group lifted their price objective on CVS Health from $80.00 to $92.00 in a report on Wednesday, October 15th. Leerink Partners lifted their target price on shares of CVS Health from $86.00 to $95.00 and gave the company an "outperform" rating in a research note on Thursday. Cowen reissued a "buy" rating on shares of CVS Health in a report on Monday, August 4th. Mizuho boosted their target price on CVS Health from $76.00 to $88.00 and gave the stock an "outperform" rating in a report on Thursday, October 9th. Finally, Zacks Research downgraded CVS Health from a "strong-buy" rating to a "hold" rating in a report on Monday, September 8th. Two research analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $82.57.

Insiders Place Their Bets

In related news, Director Anne A. Finucane sold 7,500 shares of the business's stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the transaction, the director owned 22,156 shares in the company, valued at $1,573,519.12. The trade was a 25.29% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 1.22% of the stock is owned by company insiders.

CVS Health Stock Performance

CVS stock opened at $82.64 on Monday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62. The company has a 50 day moving average price of $74.00 and a 200 day moving average price of $68.12. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $82.88. The stock has a market capitalization of $104.81 billion, a PE ratio of 23.08, a price-to-earnings-growth ratio of 0.91 and a beta of 0.60.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.46 by $0.35. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The firm had revenue of $98.92 billion during the quarter, compared to analysts' expectations of $94.87 billion. During the same quarter in the previous year, the company posted $1.83 EPS. CVS Health's revenue was up 8.4% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Analysts forecast that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be given a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.2%. The ex-dividend date is Thursday, October 23rd. CVS Health's payout ratio is 74.30%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.